查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2016044

呼吸系统诊断市场报告：按产品和服务类型、测试类型、疾病、最终用户和地区划分，2026-2034 年

Respiratory Diagnostics Market Report by Product and Service Type, Test Type, Disease, End-User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

2025年全球呼吸系统诊断市场规模达91亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到159亿美元，2026年至2034年的复合年增长率为6.17%。推动市场成长的因素包括呼吸系统疾病盛行率上升、医疗保健成本增加、人口老化以及对早期准确诊断的需求不断增长，以改善患者预后并有效管理慢性疾病。

呼吸系统诊断是指对肺功能及相关过程进行临床评估。这包括多种机械、影像和分子诊断测试，用于检测气喘、慢性阻塞性肺病（COPD）、肺癌、支气管炎和肺纤维化。这些检查包括肺量计检查、血氧饱和度测量、经皮二氧化碳监测、鼻吸气压力（SNIP）测量、胸部X光检查和电脑断层扫描（CT）。在某些情况下，可能需要进行睡眠研究，以诊断和评估是否有睡眠呼吸中止症或夜间低通气。

呼吸系统疾病盛行率的上升是市场成长的主要驱动力之一。吸烟率和饮酒量的增加，加上久坐的生活方式和压力大的日常生活，导致慢性阻塞性肺病（COPD）和肺癌等严重呼吸系统疾病的发生率上升。此外，呼吸系统诊断检测领域的各种技术创新，包括在COPD的诊断和门诊管理中应用物联网（IoT）和人工智慧（AI），也对市场成长产生了积极影响。各私立医院和医疗中心对呼吸系统诊断设备的需求不断增长，以及政府和非政府组织（NGO）为确保人人享有优质医疗保健所做的努力，也推动了呼吸系统诊断市场的发展。其他促进市场成长的因素包括研发投入的增加、老年人口的成长、快速的都市化和工业化进程，以及日益严重的全球污染。

本报告解答的主要问题：

  • 迄今为止，全球市场的发展趋势是什么？您认为未来几年这些趋势将如何演变？
  • 全球呼吸系统诊断市场的驱动因素、限制因素和近期机会是什么？
  • 各个驱动因素、限制因素和机会如何影响全球市场？
  • 主要区域市场有哪些？
  • 哪个国家是最具吸引力的市场？
  • 依产品/服务类型分類的市场区隔如何？
  • 市场上最具吸引力的产品/服务类型是什么？
  • 按测试类型分類的市场区隔如何？
  • 市面上哪种类型的检测最具吸引力？
  • 按疾病分類的市场区隔如何？
  • 目前市面上最受关注的疾病是什么？
  • 依最终用户分類的市场区隔如何？
  • 市场上最具吸引力的终端用户群是哪一类？
  • 该市场的竞争结构是怎么样的？
  • 全球市场的主要参与者/公司有哪些？

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球呼吸系统诊断市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场区隔：依产品/服务类型
  • 市场区隔：按测试类型
  • 市场区隔：依疾病分类
  • 市场区隔：依最终用户划分
  • 市场区隔：按地区
  • 市场预测

第六章 市场区隔：依产品/服务类型划分

  • 设备和服务
  • 检测方法和试剂
  • 服务软体

第七章 市场区隔：依测试类型划分

  • 机械测试
  • 阻塞型睡眠呼吸中止症）的诊断测试
  • 影像检查
  • 常规诊断测试
  • 分子诊断测试
  • 其他的

第八章 市场区隔：依疾病分类

  • 结核
  • 气喘
  • 慢性阻塞性肺病（COPD）
  • 肺癌
  • 其他的

第九章 市场区隔：依最终用户划分

  • 医院
  • 诊所
  • 实验室/临床检查室
  • 其他的

第十章 市场区隔：依地区划分

  • 北美洲
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 拉丁美洲

第十一章 SWOT 分析

第十二章：价值链分析

第十三章：波特五力分析

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Philips Healthcare
    • Abbott Laboratories
    • Biomerieux
    • Becton Dickinson
    • Thermo Fisher Scientific Inc.
    • Alere Inc.
    • Seegene Inc.
    • 3M
    • Bio-Rad Laboratories Inc.
    • SDI Diagnostics
    • COSMED
Product Code: SR112026A1620

The global respiratory diagnostics market size reached USD 9.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 15.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6.17% during 2026-2034. The growing prevalence of respiratory diseases, rising healthcare expenditure, increasing aging population, and heightened demand for early and accurate diagnosis to improve patient outcomes and manage chronic conditions effectively are some of the factors impelling the market growth.

Respiratory diagnostics refer to the clinical assessment of lung functioning and related processes. It includes several mechanical, imaging and molecular diagnostic tests for detecting asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. It uses procedures, such as spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray and computed tomography (CT) scan. In some instances, sleep studies are also conducted to diagnose and assess the presence of sleep apnea and nocturnal hypoventilation.

The growing prevalence of respiratory diseases is one of the key factors driving the growth of the market. The increasing number of smokers and consumption of alcohol, coupled with sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung cancer. Furthermore, various technological innovations in respiratory diagnostic testing, including the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth. Also, an increase in the demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers and efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all are driving the market for respiratory diagnostics. Other factors contributing to the market growth include enhanced research and development (R&D), rising geriatric population, rapid urbanization and increasing industrial establishments, and growing pollution levels across the globe.

Key Market Segmentation:

The publisher provides an analysis of the key respiratory diagnostics market trends in each segment, along with forecasts at the global and regional levels for 2026-2034. Our report has categorized the market based on product and service type, test type, disease, and end-user.

Breakup by Product and Service Type:

  • Instruments and Services
  • Assays and Reagents
  • Services and Software

Breakup by Test Type:

  • Mechanical Tests
  • Obstructive Sleep Apnoea (OSA) Diagnostic Tests
  • Imaging Tests
  • Traditional Diagnostic Tests
  • Molecular Diagnostic Tests
  • Others

Breakup by Disease:

  • Tuberculosis
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Lung Cancer
  • Others

Breakup by End-User:

  • Hospitals
  • Clinics
  • Reference and Clinical Laboratories
  • Others

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific Inc., Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics and COSMED.

Key Questions Answered in This Report:

  • How has the global market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and respiratory diagnostics market recent opportunities in the global market?
  • What is the impact of each driver, restraint, and opportunity on the global market?
  • What are the key regional markets?
  • Which countries represent the most attractive market?
  • What is the breakup of the market based on the product and service type?
  • Which is the most attractive product and service type in the market?
  • What is the breakup of the market based on the test type?
  • Which is the most attractive test type in the market?
  • What is the breakup of the market based on the disease?
  • Which is the most attractive disease in the market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Respiratory Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product and Service Type
  • 5.5 Market Breakup by Test Type
  • 5.6 Market Breakup by Disease
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product and Service Type

  • 6.1 Instruments and Services
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Assays and Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services and Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Mechanical Tests
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Obstructive Sleep Apnoea (OSA) Diagnostic Tests
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Imaging Tests
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Traditional Diagnostic Tests
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Molecular Diagnostic Tests
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Tuberculosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Asthma
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Chronic Obstructive Pulmonary Disease (COPD)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Lung Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Reference and Clinical Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Philips Healthcare
    • 14.3.2 Abbott Laboratories
    • 14.3.3 Biomerieux
    • 14.3.4 Becton Dickinson
    • 14.3.5 Thermo Fisher Scientific Inc.
    • 14.3.6 Alere Inc.
    • 14.3.7 Seegene Inc.
    • 14.3.8 3M
    • 14.3.9 Bio-Rad Laboratories Inc.
    • 14.3.10 SDI Diagnostics
    • 14.3.11 COSMED

List of Figures

  • Figure 1: Global: Respiratory Diagnostics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 2: Global: Respiratory Diagnostics Market: Breakup by Product and Service Type (in %), 2025
  • Figure 3: Global: Respiratory Diagnostics Market: Breakup by Test Type (in %), 2025
  • Figure 4: Global: Respiratory Diagnostics Market: Breakup by Disease (in %), 2025
  • Figure 5: Global: Respiratory Diagnostics Market: Breakup by End User (in %), 2025
  • Figure 6: Global: Respiratory Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Respiratory Diagnostics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 8: Global: Respiratory Diagnostics Industry: SWOT Analysis
  • Figure 9: Global: Respiratory Diagnostics Industry: Value Chain Analysis
  • Figure 10: Global: Respiratory Diagnostics Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Respiratory Diagnostics (Instruments and Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Respiratory Diagnostics (Instruments and Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Respiratory Diagnostics (Assays and Reagents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Respiratory Diagnostics (Assays and Reagents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Respiratory Diagnostics (Services and Software) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Respiratory Diagnostics (Services and Software) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Respiratory Diagnostics (Mechanical Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Respiratory Diagnostics (Mechanical Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Respiratory Diagnostics (Imaging Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Respiratory Diagnostics (Imaging Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Respiratory Diagnostics (Other Test Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Respiratory Diagnostics (Other Test Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Respiratory Diagnostics (Tuberculosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Respiratory Diagnostics (Tuberculosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Respiratory Diagnostics (Asthma) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Respiratory Diagnostics (Asthma) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Respiratory Diagnostics (Lung Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Respiratory Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Respiratory Diagnostics (Other Disease Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Respiratory Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Respiratory Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Respiratory Diagnostics (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Respiratory Diagnostics (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Respiratory Diagnostics (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Respiratory Diagnostics (Other End-Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Respiratory Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: North America: Respiratory Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: North America: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Europe: Respiratory Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Europe: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Asia Pacific: Respiratory Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Asia Pacific: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Middle East and Africa: Respiratory Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Middle East and Africa: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Latin America: Respiratory Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Latin America: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034

List of Tables

  • Table 1: Global: Respiratory Diagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Respiratory Diagnostics Market Forecast: Breakup by Product and Service Type (in Million USD), 2026-2034
  • Table 3: Global: Respiratory Diagnostics Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 4: Global: Respiratory Diagnostics Market Forecast: Breakup by Disease (in Million USD), 2026-2034
  • Table 5: Global: Respiratory Diagnostics Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 6: Global: Respiratory Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Respiratory Diagnostics Market Structure
  • Table 8: Global: Respiratory Diagnostics Market: Key Players